Pegasus
Evaluates the safety and effectiveness of the drug ticagrelor in long-term use, one to three years after the patient has had a heart attack, in addition to aspirin therapy. Principal Investigator: P. Kasi Ramanathan, MD, FACC Contact the research coordinator: Tiffanie Barnhizer, RN |